These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 11332994)
1. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes. Campbell M; Aprelikova ON; van der Meer R; Woltjer RL; Yee CJ; Liu ET; Jensen RA Cancer Gene Ther; 2001 Mar; 8(3):231-9. PubMed ID: 11332994 [TBL] [Abstract][Full Text] [Related]
2. Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesis. Xu X; Qiao W; Linke SP; Cao L; Li WM; Furth PA; Harris CC; Deng CX Nat Genet; 2001 Jul; 28(3):266-71. PubMed ID: 11431698 [TBL] [Abstract][Full Text] [Related]
3. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells. Gudas JM; Li T; Nguyen H; Jensen D; Rauscher FJ; Cowan KH Cell Growth Differ; 1996 Jun; 7(6):717-23. PubMed ID: 8780885 [TBL] [Abstract][Full Text] [Related]
4. The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers. Marot D; Opolon P; Brailly-Tabard S; Elie N; Randrianarison V; Connault E; Foray N; Feunteun J; Perricaudet M Gene Ther; 2006 Feb; 13(3):235-44. PubMed ID: 16208422 [TBL] [Abstract][Full Text] [Related]
5. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760 [TBL] [Abstract][Full Text] [Related]
6. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668 [TBL] [Abstract][Full Text] [Related]
7. A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells. Larson JS; Tonkinson JL; Lai MT Cancer Res; 1997 Aug; 57(16):3351-5. PubMed ID: 9269994 [TBL] [Abstract][Full Text] [Related]
8. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines. Slebos RJ; Taylor JA Biochem Biophys Res Commun; 2001 Feb; 281(1):212-9. PubMed ID: 11178982 [TBL] [Abstract][Full Text] [Related]
9. Growth retardation and tumour inhibition by BRCA1. Holt JT; Thompson ME; Szabo C; Robinson-Benion C; Arteaga CL; King MC; Jensen RA Nat Genet; 1996 Mar; 12(3):298-302. PubMed ID: 8589721 [TBL] [Abstract][Full Text] [Related]
10. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [TBL] [Abstract][Full Text] [Related]
12. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo. Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499 [TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of a breast cell strain containing a BRCA1 185delAG mutation. Annab LA; Terry L; Cable PL; Brady J; Stampfer MR; Barrett JC; Afshari CA Gynecol Oncol; 2000 Apr; 77(1):121-8. PubMed ID: 10739701 [TBL] [Abstract][Full Text] [Related]
14. BRCA1 deficient embryonic stem cells display a decreased homologous recombination frequency and an increased frequency of non-homologous recombination that is corrected by expression of a brca1 transgene. Snouwaert JN; Gowen LC; Latour AM; Mohn AR; Xiao A; DiBiase L; Koller BH Oncogene; 1999 Dec; 18(55):7900-7. PubMed ID: 10630642 [TBL] [Abstract][Full Text] [Related]
15. Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathway. Bao JJ; Le XF; Wang RY; Yuan J; Wang L; Atkinson EN; LaPushin R; Andreeff M; Fang B; Yu Y; Bast RC Cancer Res; 2002 Dec; 62(24):7264-72. PubMed ID: 12499268 [TBL] [Abstract][Full Text] [Related]
16. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells. Vaughn JP; Davis PL; Jarboe MD; Huper G; Evans AC; Wiseman RW; Berchuck A; Iglehart JD; Futreal PA; Marks JR Cell Growth Differ; 1996 Jun; 7(6):711-5. PubMed ID: 8780884 [TBL] [Abstract][Full Text] [Related]
17. Generation and analysis of Brca1 conditional knockout mice. Deng CX; Xu X Methods Mol Biol; 2004; 280():185-200. PubMed ID: 15187254 [TBL] [Abstract][Full Text] [Related]
18. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1]. Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716 [TBL] [Abstract][Full Text] [Related]
19. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma]. Song Y; Shen K; He CX Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518 [TBL] [Abstract][Full Text] [Related]
20. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]